Heidrich H, Lammersen T
Dtsch Med Wochenschr. 1985 Aug 23;110(34):1283-5. doi: 10.1055/s-2008-1068996.
The ability of a single i. v. application of 40 micrograms alprostadil (PGE1, mean therapeutic dose 0.62 microgram/kg body weight) to cause changes in capillary microscopy parameters and tcpO2 was investigated in an open study in 15 patients with peripheral arterial occlusive disease, Fontaine stage II-IV (8 women and 7 men, average age 70.1 and 70.0 years, respectively). Capillary microscopy investigations and oxygen tension measurements were carried out before and immediately after i. v. infusion of PGE1 or a 5% solution of laevulose using an intra-individual comparison. PGE1 led to an increase in the number of erythrocyte-filled capillaries per mm2, an improvement in the initial condition of the capillaries evaluated according to Fagrell and to a significant increase in the tcpO2, whereas no haemodynamic changes occurred at all after laevulose. These findings substantiate the view that PGE1 is also effective when applied intravenously distal from the arterial occlusion.
在一项开放性研究中,对15例处于Fontaine II-IV期外周动脉闭塞性疾病患者(8名女性和7名男性,平均年龄分别为70.1岁和70.0岁)进行了研究,以探究单次静脉注射40微克前列地尔(PGE1,平均治疗剂量0.62微克/千克体重)引起毛细血管显微镜检查参数和经皮氧分压(tcpO2)变化的能力。使用个体内对照,在静脉输注PGE1或5%果糖溶液之前和之后立即进行毛细血管显微镜检查和氧张力测量。PGE1导致每平方毫米内充满红细胞的毛细血管数量增加,根据法格雷尔标准评估的毛细血管初始状态得到改善,并且tcpO2显著增加,而果糖输注后未发生任何血流动力学变化。这些发现证实了以下观点:当在动脉闭塞远端静脉应用时,PGE1也是有效的。